Genetic prion disease: opportunities for early therapeutic intervention with rigorous pre-symptomatic trials

Expert Opin Investig Drugs. 2020 Dec;29(12):1313-1316. doi: 10.1080/13543784.2020.1839048. Epub 2020 Nov 1.

Authors

Peter Hermann^{1

2}, Jan C Koch², Inga Zerr^{1

2

3}

Affiliations

¹ National Reference Center for TSE, University Medical Center Göttingen , Göttingen, Germany.
² Department of Neurology, University Medical Center Göttingen , Göttingen, Germany.
³ German Center for Neurodegenerative Diseases (DZNE) , Göttingen, Germany.

PMID: 33089731
DOI: 10.1080/13543784.2020.1839048

No abstract available

Publication types

Editorial

MeSH terms

Animals
Humans
Mutation
Prion Diseases / drug therapy
Prion Diseases / genetics*
Prion Proteins / genetics*
Research Design

Substances

PRNP protein, human
Prion Proteins